Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.
Funding
Medical services group Danel led a $40m series B round yesterday for Aviv Scientific, an Israel-based developer of oxygen therapy treatments to address age-related cognitive decline. The round included the deep technology-focused Deep Insight Fund and although Aviv has not revealed details of past funding, its technology stems from a partnership with Sagol Center, a hyperbaric medicine and research facility located at Shamir Medical Center.
US-based drug delivery technology developer Credence MedSystems completed a $39.9m funding round yesterday that…
